Ondansetron-induced QT prolongation among various age groups: a systematic review and meta-analysis
Abstract Background Ondansetron is a selective 5-hydroxytryptamine type 3 serotonin-receptor antagonist with antiemetic properties used inadvertently in the emergency department for controlling nausea. However, ondansetron is linked with a number of adverse effects, including prolongation of the QT...
Main Authors: | Kamaldeep Singh, Arpit Jain, Ishita Panchal, Hritik Madan, Anubhav Gupta, Aakanksha Sharma, Surabhi Gupta, Anastas Kostojchin, Anmol Singh, Ishanjit Singh Sandhu, Jayesh Mittal, Loveleen Bhogal, Shiny Teja Kolli, Vishal Reddy Bejugam, Salil Chaturvedi, Akhil Bhalla, Shobhit Piplani |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-07-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43044-023-00385-y |
Similar Items
-
Hypersensitivity reaction to intravenous ondansetron: A case report
by: Sagar Devkota, et al.
Published: (2022-09-01) -
Using ondansetron as an oral premedication drug for prevention of postanesthesia shivering
by: Ashraf A M. Soliman
Published: (2019-01-01) -
Ondansetron VS Pethidine for The Prevention of Postoperative Shivering
by: Medhat Noaman, et al.
Published: (2019-07-01) -
Ondansetron reducing pain on injection of etomidate: a controlled randomized study
by: Omid Azimaraghi, et al.
Published: (2014-06-01) -
Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
by: K Raghu, et al.
Published: (2018-01-01)